Mid Ohio Oncology Hematology, Inc. — Columbus, Ohio

Mid Ohio Oncology Hematology, Inc. is a clinical research site located in Columbus, Ohio, United States 43213.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Mid Ohio Oncology Hematology, Inc. has participated in 2 clinical trials.

Therapeutic areas: B-Cell Chronic Lymphocytic Leukemia (B-CLL), Prostate Cancer.

Sponsors: Genzyme, a Sanofi Company, Novacea.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mid Ohio Oncology Hematology, Inc.?

Mid Ohio Oncology Hematology, Inc. has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mid Ohio Oncology Hematology, Inc. conducted?

Mid Ohio Oncology Hematology, Inc. has 2 clinical trials on record. Their work covers B-Cell Chronic Lymphocytic Leukemia (B-CLL), Prostate Cancer.

Is Mid Ohio Oncology Hematology, Inc. accredited by Crixeo Health?

Mid Ohio Oncology Hematology, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mid Ohio Oncology Hematology, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.